iRadimed Corporation - Common Stock (NQ:IRMD)

79.42 UNCHANGED

Delayed Quote Updated: 4:00 PM EST, Nov 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iRadimed Corporation - Common Stock

< Previous 1 2 3 4 5 Next >

Earnings Scheduled For February 4, 2022 ↗

February 04, 2022

Companies Reporting Before The Bell • Brookfield Business (NYSE:BBU) is estimated to report earnings for its fourth quarter.

Via Benzinga

Earnings Outlook For iRadimed ↗

February 03, 2022

iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that iRadimed will likely...

Via Benzinga

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗

January 31, 2022

The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.

Via Benzinga

Recap: iRadimed Q2 Earnings ↗

July 30, 2021

Shares of iRadimed (NASDAQ:IRMD) moved higher by 0.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 180.00% over...

Via Benzinga

Earnings Outlook for iRadimed ↗

April 29, 2021

iRadimed (NASDAQ:IRMD) announces its next round of earnings this Friday, April 30. Here is Benzinga's look at iRadimed's Q1 earnings report. What Are Earnings, Net Income, And...

Via Benzinga

7 Excellent Small-Cap Stocks to Buy Before 2022 ↗

December 14, 2021

We've seen big tech rule the markets for a while, but now quality small-cap stocks are likely to begin stealing the headlines.

Via InvestorPlace

The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs ↗

October 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...

Via Benzinga

iRadimed's Earnings Outlook ↗

October 28, 2021

iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Friday, 2021-10-29. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

2 Small-Cap Healthcare Stocks To Buy And Hold For Years ↗

September 24, 2021

The rapid adoption of technologies and a push to develop therapeutics to serve an aging population have catalyzed the healthcare sector’s growth.

Via Talk Markets

Earnings Scheduled For October 29, 2021 ↗

October 29, 2021

Companies Reporting Before The Bell • Sify Technologies (NASDAQ:SIFY) is expected to report quarterly earnings at $0.02 per share on revenue of $97.70 million. •...

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Earnings Scheduled For July 30, 2021 ↗

July 30, 2021

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter. • Embraer (NYSE:ERJ) is...

Via Benzinga

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

Earnings Scheduled For April 30, 2021 ↗

April 30, 2021

Companies Reporting Before The Bell • O2Micro Intl (NASDAQ:OIIM) is estimated to report quarterly earnings at $0.09 per share on revenue of $23.30 million. • Twin...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.